MY105328A - Blocking agents of edrf effect or formation for the treatment of shock. - Google Patents

Blocking agents of edrf effect or formation for the treatment of shock.

Info

Publication number
MY105328A
MY105328A MYPI90002223A MYPI19902223A MY105328A MY 105328 A MY105328 A MY 105328A MY PI90002223 A MYPI90002223 A MY PI90002223A MY PI19902223 A MYPI19902223 A MY PI19902223A MY 105328 A MY105328 A MY 105328A
Authority
MY
Malaysia
Prior art keywords
treatment
shock
edrf
formation
effect
Prior art date
Application number
MYPI90002223A
Other languages
English (en)
Inventor
Auguet Michel
Chabrier De Lassauniere Pierre-Etienne
Braquet Pierre
Guillon Jean-Michel
Original Assignee
Soc De Conseils De Recherches Et Dapplications Scientifiques S C R A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc De Conseils De Recherches Et Dapplications Scientifiques S C R A S filed Critical Soc De Conseils De Recherches Et Dapplications Scientifiques S C R A S
Publication of MY105328A publication Critical patent/MY105328A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MYPI90002223A 1989-12-22 1990-12-20 Blocking agents of edrf effect or formation for the treatment of shock. MY105328A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898929076A GB8929076D0 (en) 1989-12-22 1989-12-22 Treatment of shock by blocking agents of edrf effect or formation

Publications (1)

Publication Number Publication Date
MY105328A true MY105328A (en) 1994-09-30

Family

ID=10668428

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI90002223A MY105328A (en) 1989-12-22 1990-12-20 Blocking agents of edrf effect or formation for the treatment of shock.

Country Status (21)

Country Link
US (1) US5081148A (enEXAMPLES)
JP (1) JP2706578B2 (enEXAMPLES)
KR (1) KR950005866B1 (enEXAMPLES)
AT (1) AT403122B (enEXAMPLES)
AU (1) AU629777B2 (enEXAMPLES)
BE (1) BE1005531A5 (enEXAMPLES)
CA (1) CA2032904C (enEXAMPLES)
CH (1) CH681692A5 (enEXAMPLES)
DE (1) DE4041283C2 (enEXAMPLES)
DK (1) DK176168B1 (enEXAMPLES)
FR (1) FR2656220B1 (enEXAMPLES)
GB (2) GB8929076D0 (enEXAMPLES)
HK (1) HK134693A (enEXAMPLES)
IE (1) IE64403B1 (enEXAMPLES)
IT (1) IT1246511B (enEXAMPLES)
LU (1) LU87867A1 (enEXAMPLES)
MY (1) MY105328A (enEXAMPLES)
NL (1) NL194717C (enEXAMPLES)
OA (1) OA09337A (enEXAMPLES)
SE (1) SE504922C2 (enEXAMPLES)
ZA (1) ZA9010004B (enEXAMPLES)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
ES2181726T3 (es) * 1993-10-21 2003-03-01 Searle & Co Amidinoderivados utiles como inhibidores de oxido nitrico sintasa.
ATE177078T1 (de) * 1993-10-21 1999-03-15 Searle & Co Amidino-derivate als no-synthetase inhibitoren
GB9404400D0 (en) * 1994-03-07 1994-04-20 Wood Pauline J Potentiation of bioreductive agents
DE69518631T2 (de) * 1994-03-10 2001-01-11 G.D. Searle & Co., Chicago L-n6-(1-iminoethyl)lysin - derivate und ihre verwendung als no-synthase - inhibitoren
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
FR2727111B1 (fr) * 1994-11-21 1997-01-17 Hoechst Lab Nouveaux analogues soufres d'aminoacides, leur procede de preparation et leurs applications comme medicaments
CA2206119C (en) * 1994-12-12 2008-05-13 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
GB9504350D0 (en) * 1995-03-04 1995-04-26 Sod Conseils Rech Applic Arginine derivatives
CN1105706C (zh) * 1995-04-20 2003-04-16 G·D·瑟尔公司 用作氧化氮合成酶抑制剂的环状脒基制剂
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
BR9509985A (pt) * 1995-12-12 1998-11-03 Omeros Med Sys Inc Solução para irrigação e método para inibição de dor inflamação e esparmo
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US6620848B2 (en) 1997-01-13 2003-09-16 Smithkline Beecham Corporation Nitric oxide synthase inhibitors
US6369272B1 (en) 1997-01-13 2002-04-09 Glaxosmithkline Nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
GB9811599D0 (en) 1998-05-30 1998-07-29 Glaxo Group Ltd Nitric oxide synthase inhibitors
JP2002517502A (ja) 1998-06-10 2002-06-18 ジー・ディー・サール・アンド・カンパニー 複素二環状及び三環状一酸化窒素シンターゼ阻害剤
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
WO2005063752A1 (en) 2003-12-30 2005-07-14 Vasopharm Biotech Gmbh 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
DE1767212B1 (de) * 1967-04-13 1971-05-06 Sumitomo Chemical Co Verfahren zur Herstellung injizierbarer Arzneimittel
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
CA1029660A (en) * 1973-06-01 1978-04-18 Kyowa Hakko Kogyo Co. Prevention of gastric lesions
FR2320759A1 (fr) * 1975-08-11 1977-03-11 Union Pharma Scient Appl Solution d'acide acetylsalicylique extemporanee injectable
IT1127321B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi
IT1127322B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
JPS5781409A (en) * 1980-11-10 1982-05-21 Toko Yakuhin Kogyo Kk External plaster
JPS57197211A (en) * 1981-05-28 1982-12-03 Sumitomo Chem Co Ltd Useful eye drop composition
JPS57200361A (en) * 1981-06-03 1982-12-08 Sumitomo Chem Co Ltd "indomethacin(r)" pharmaceutical with low irritant action
JPS6239524A (ja) * 1985-08-13 1987-02-20 Toko Yakuhin Kogyo Kk 消炎鎮痛軟膏剤
JPH0236570B2 (ja) * 1985-05-30 1990-08-17 Toko Yakuhin Kogyo Kk Shoenchintsunankozai
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
DE3878812T2 (de) * 1987-02-20 1993-07-22 Shriners Hospitals For Cripple Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.

Also Published As

Publication number Publication date
BE1005531A5 (fr) 1993-09-28
JP2706578B2 (ja) 1998-01-28
DK304190D0 (da) 1990-12-21
IT9022413A1 (it) 1991-06-23
GB2240041B (en) 1993-09-01
IE904592A1 (en) 1991-07-03
KR910011253A (ko) 1991-08-07
DE4041283A1 (de) 1991-06-27
FR2656220B1 (fr) 1995-01-13
FR2656220A1 (fr) 1991-06-28
DE4041283C2 (de) 2000-07-13
ZA9010004B (en) 1991-10-30
LU87867A1 (fr) 1991-05-07
NL194717C (nl) 2003-01-07
KR950005866B1 (ko) 1995-06-02
AU6837690A (en) 1991-06-27
AT403122B (de) 1997-11-25
GB9028013D0 (en) 1991-02-13
CA2032904C (en) 1996-01-02
CH681692A5 (enEXAMPLES) 1993-05-14
IT9022413A0 (it) 1990-12-18
GB2240041A (en) 1991-07-24
SE9003974D0 (sv) 1990-12-12
NL9002720A (nl) 1991-07-16
ATA260690A (de) 1997-04-15
AU629777B2 (en) 1992-10-08
SE504922C2 (sv) 1997-05-26
US5081148A (en) 1992-01-14
SE9003974L (sv) 1991-06-23
IE64403B1 (en) 1995-08-09
GB8929076D0 (en) 1990-02-28
HK134693A (en) 1993-12-17
CA2032904A1 (en) 1991-06-23
OA09337A (fr) 1992-09-15
DK304190A (da) 1991-06-23
NL194717B (nl) 2002-09-02
JPH04364124A (ja) 1992-12-16
DK176168B1 (da) 2006-11-13
IT1246511B (it) 1994-11-19

Similar Documents

Publication Publication Date Title
MY105328A (en) Blocking agents of edrf effect or formation for the treatment of shock.
IL93556A0 (en) Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
GR3032083T3 (en) Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
ATE183081T1 (de) Doxorubicine enkapsulierende liposomen
EP0765865A4 (en) 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION
CA2444071A1 (en) Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
TW334434B (en) Novel quinazoline compound and anti-tumor agent
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
PL295932A1 (en) Method of obtaining novel bezazepine compounds
IL99898A0 (en) 7-acyl-3-substituted carbamoyloxy cephem compounds,their preparation and antibacterial compositions containing them
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
ES2058085T3 (es) Composicion anticonvulsivante que contiene un derivado de aminoacido, y utilizacion de dicho derivado de aminoacido.
WO1990012577A3 (en) Topical anti-angiogenic as hair growth inhibitors
IL103826A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES2071786T3 (es) Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso.
IE902273L (en) Compositions of 5-phenyl-2-furan esters amides and ketones
IL111791A0 (en) Glutaramide derivatives
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ES2118846T3 (es) Formas cristalinas de monohidrato de hidrocloruro de endo-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamida y de monohidrato de hidrocloruro de endo-3-etil-2,3-dihidro-n-(8-metil-8-azabiciclo(3.2.1)oct-3-il)-2-oxo-1h-bencimidazol-1-carboxamid
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES8102126A1 (es) Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina
IL114646A (en) Pharmaceutical compositions containing phenylurea derivatives for inhibiting leukotriene biosynthesis